Cargando…
Efficacy and Safety of Nadifloxacin for Bacterial Skin Infections: Results from Clinical and Post-Marketing Studies
INTRODUCTION: Skin and soft tissue infections involve microbial invasion of the skin and underlying soft tissues and are estimated to affect 7–10% of hospitalized patients worldwide. Nadifloxacin, a topical fluoroquinolone, has been shown to be effective against aerobic Gram-negative, Gram-positive...
Autores principales: | Narayanan, Varsha, Motlekar, Salman, Kadhe, Ganesh, Bhagat, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257952/ https://www.ncbi.nlm.nih.gov/pubmed/25212256 http://dx.doi.org/10.1007/s13555-014-0062-1 |
Ejemplares similares
-
A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children
por: Rao, Sameer, et al.
Publicado: (2016) -
Efficacy and Tolerability of Topical Fixed Combination of Nadifloxacin 1% and Adapalene 0.1% in the Treatment of Mild to Moderate Acne Vulgaris in Indian Patients: A Multicenter, Open-Labelled, Prospective Study
por: Shah, Bela Jaswantlal, et al.
Publicado: (2014) -
Co-crystal of nadifloxacin with oxalic acid
por: Karthammaiah, Geethanjali N., et al.
Publicado: (2023) -
Design and Evaluation of Microemulsion Gel System of Nadifloxacin
por: Shinde, Ujwala, et al.
Publicado: (2012) -
Evidence-Based Treatment for Melasma: Expert Opinion and a Review
por: Shankar, Krupa, et al.
Publicado: (2014)